Oncology Group Lays Out Basis For Potential Lawsuit If Part B Drug Pay Demo Proceeds

By Michelle M. Stein / June 23, 2016 at 1:11 PM
The Community Oncology Alliance has warned CMS to expect a possible lawsuit should the agency move forward with the proposed Part B drug cost-control demonstration, previewing its potential legal case in a letter to the agency. Ted Okon, executive director of COA, says the group has tried to be transparent with its concerns so no one should be shocked if the group moves forward with legal action. “Please understand that we are actively pursuing every legal, legislative and related option...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.